Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Revenues	$ 13,942	$ 13,875
Cost of revenues	6,081	6,381
Gross profit	7,861	7,494
Selling, general and administrative expenses	930,907	560,525
Research and development	351,050	137,999
Amortization	2,730	2,730
Operating loss	(1,276,826)	(680,964)
Other (expense) income:
Interest expense	(406,325)	(105,224)
Grant income	38,758	12,796
Net loss	(1,644,393)	(786,188)
Net loss attributable to noncontrolling interest	(66,972)	(5,756)
Net loss attributable to common shareholders	$ (1,577,421)	$ (780,432)
Loss per share attributable to shareholders – basic and diluted (in dollars per share)	$ (0.02)	$ (0.01)
Weighted average number of common shares outstanding: (in shares)	85,847,219	82,973,744
Net loss	$ (1,644,393)	$ (786,188)
Foreign currency translation	(9,318)
Comprehensive loss	(1,653,711)	$ (786,188)
Comprehensive loss attributable to noncontrolling interest	(66,972)	(5,756)
Comprehensive loss attributable to common shareholders	$ (1,586,739)	$ (780,432)